Diabetes Research and Clinical Practice
Volume 61, Issue 2 , Pages 93-101 , August 2003

Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy

  • Naoto Nakamura

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-75-251-5505; fax: +81-75-252-3721
    • ,
  • Goji Hasegawa

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • ,
  • Hiroshi Obayashi

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • ,
  • Masahiro Yamazaki

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • ,
  • Masakazu Ogata

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • ,
  • Koji Nakano

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • ,
  • Toshikazu Yoshikawa

      Affiliations

    • First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602-0841, Japan
    • ,
  • Akihide Watanabe

      Affiliations

    • Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
    • ,
  • Shigeru Kinoshita

      Affiliations

    • Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
    • ,
  • Aya Fujinami

      Affiliations

    • Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan
    • ,
  • Mitsuhiro Ohta

      Affiliations

    • Department of Clinical Chemistry, Kobe Pharmaceutical University, Kobe, Japan
    • ,
  • Yutaka Imamura

      Affiliations

    • Department of Ophthalmology, Osaka Medical College, Osaka, Japan
    • ,
  • Tsunehiko Ikeda

      Affiliations

    • Department of Ophthalmology, Osaka Medical College, Osaka, Japan

Received 6 January 2003 ,Revised 1 April 2003 ,Accepted 16 April 2003.

References 

  1. Grant M, Russell B, Fitzgerald C, Merimee TJ. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization. Diabetes. 1986;35:416–420
  2. Sivalingam A, Kenney J, Brown GC, Benson WE, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch. Ophthalmol. 1990;108:869–872
  3. Adamis AP, Miller JW, Bernal MT, et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1994;118:445–450
  4. Aiello LP, Avery RL, Arrigg PG, et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New Engl. J. Med. 1994;331:480–487
  5. Hirata C, Nakano K, Nakamura N, Kitagawa Y, et al.  Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem. Biophys. Res. Commun. 1997;236:712–715
  6. Hirase K, Ikeda T, Sotozono C, Nishida K, Sawa H, Kinoshita S. Transforming growth factor b2 in the vitreous in proliferative diabetic retinopathy. Arch. Ophthalmol. 1998;116:738–741
  7. Katsura Y, Okano T, Noritake M, et al.  Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Diabetes Care. 1998;21:1759–1763
  8. Nishimura M, Ikeda T, Ushiyama M, Nanbu A, Kinoshita S, Yoshimura M. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J. Clin. Endocrinol. Metab. 1999;84:659–662
  9. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 1994;70:138–151
  10. Sebag J, Buckingham B, Charles MA, Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch. Ophthalmol. 1992;110:1472–1476
  11. Stitt AW, Moore JE, Sharkey JA, et al.  Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest. Ophthalmol. Vis. Sci. 1998;39:2517–2523
  12. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today. 1990;11:443–449
  13. Lotz M. Interleukin-6: a comprehensive review. Cancer Treat. Res. 1995;80:209–233
  14. Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM. Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells. Exp. Eye Res. 1992;54:361–368
  15. Planck SR, Dang TT, Graves D, Tara D, Ansel JC, Rosenbaum JT. Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest. Ophthalmol. Vis. Sci. 1992;33:78–82
  16. Benson MT, Shepherd L, Rees RC, Rennie IG. Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines. Curr. Eye Res. 1992;11(Suppl.):173–179
  17. Cubitt CL, Lausch RN, Oakes JE. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 1995;36:330–336
  18. Knisely TL, Grabbe S, Nazareno R, Granstein RD. Production of interleukin-6 and granulocyte-macrophage colony-stimulating factor by murine iris and ciliary body explants. Invest. Ophthalmol. Vis. Sci. 1994;35:4015–4022
  19. Yoshida S, Sotozono C, Ikeda T, Kinoshita S. Interleukin-6 (IL-6) production by cytokine-stimulated human Muller cells. Curr. Eye Res. 2001;22:341–347
  20. Abu el Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1992;114:731–736
  21. Funatsu H, Yamashita H, Shimizu E, Kojima R, Hori S. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina. 2001;21:469–477
  22. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 1996;271:736–741
  23. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem. 1989;264(36):21597–21602
  24. Sanaka T, Funaki T, Tanaka T, Higuchi C, et al.  Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure. Nephron. 2002;91:64–73
  25. Shikano M, Sobajima H, Yoshikawa H, et al.  Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron. 2000;85:81–85
  26. Nakamura K, Hasegawa T, Fukunaga Y, Ienaga K. Crossline A and B as candidates for the fluorophores in age- and diabetes-related crosslinked protein and their diabetes produced by Maillard reaction of a-N-acetyl-l-lysine with d-glucose. J. Chem. Soc. Chem. Commun. 1992;14:992–994
  27. Obayashi H, Nakano K, Shigeta H, et al.  Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo. Biochem. Biophys. Res. Commun. 1996;226:37–41
  28. Ideta R, Yamashita H, Tanaka Y, Kato S, Kitano S, Hori S. Roles of cytokines in diabetic retinopathy. Arch. Ophthalmol. 1999;117:700–701
  29. Morohoshi M, Fujisawa K, Uchimura I, Numano F. The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann. New York Acad. Sci. 1995;748:562–570
  30. Takagi M, Kasayama S, Yamamoto T, et al.  Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells. J. Bone Miner. Res. 1997;12:439–446
  31. Reichenbach A, Stolzenburg JU, Eberhardt W, et al.  What do retinal muller (glial) cells do for their neuronal ‘small siblings’. J. Chem. Neuroanat. 1993;6:201–213
  32. Tout S, Chan-Ling T, Hollander H, Stone J. The role of Muller cells in the formation of the blood–retinal barrier. Neuroscience. 1993;55:291–301
  33. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131:710–714

PII: S0168-8227(03)00109-8

doi: 10.1016/S0168-8227(03)00109-8

Diabetes Research and Clinical Practice
Volume 61, Issue 2 , Pages 93-101 , August 2003

Article Tools

* Image Usage & Resolution